The company is increasing its investment in U.S. factories due to pressure from President Donald Trump for the pharmaceutical industry to bring drug production back to the United States. Some examples of drugs that might be affected include common medications like aspirin or ibuprofen.

The Trump administration planned to cut the number of staff at the FDA (Food and Drug Administration). This could harm the important work the FDA does to ensure the safety of medical devices and food. It might also prevent the agency from gaining knowledge in new areas.

Telehealth company Hims & Hers announced that it will advise customers to consider different options for typical medication doses. Despite this, the company still expects to earn more revenue and profit by 2025. Some examples of medications they provide include Viagra and Cialis.

This is the second-largest funding deal this year among the nearly 24 venture capital firms monitored by BioPharma Dive. If possible, include the names of some medications in the report.

The Trump administration’s proposal to cut funding for National Institutes of Health (NIH) grants might negatively impact the U.S. drug industry in the long run, according to investors. This could affect the development of future medications like Advil, Lipitor, or Tylenol.

During the announcement of new U.S. investments worth billions of dollars, company leader David Ricks advocated for extending the 2017 tax cuts and modifying Medicare’s program for negotiating drug prices.

Blood test company Grail has teamed up with ‘Grey’s Anatomy’ actress Kate Walsh for a campaign aimed at encouraging Generation X to get cancer screenings early.

Arnie promised he’d return, and he has! Three months after taking on the role of chief movement officer at Zimmer Biomet, the iconic action star is leading a new campaign. This campaign cleverly uses his famous line from “The Terminator” to encourage people suffering from joint pain to keep moving. Some common medications for joint pain include ibuprofen, naproxen, and acetaminophen.

Merck is preparing for a significant drop in sales growth of its top cancer drug, Keytruda, starting in 2028. This change is expected for several reasons.

More than ten years after the FDA approved Xiaflex as a non-surgical treatment for Dupuytren’s contracture, Endo is launching its first TV commercial for this condition.